🔔 Update on access to Zoladex treatment

We heard your concerns about AstraZeneca's decision to discontinue Zoladex 3.6mg from 1 November 2026 - and we went to work on your behalf.

After coordinating advocacy with clinicians, consumers and key stakeholders, we're pleased to share that options will be available for those affected, including a free access program for eligible patients and work underway on alternative treatment pathways.

Supply continues in the meantime and we'll keep you informed every step of the way.

Full details available through the link in our bio. If you need support, our Helpline is here for you on 

👉 Reach out to the BCNA Helpline 1800 500 258 for information and support

Read more here:
🔗 https://www.bcna.org.au/latest-news/bcna-news/update-on-access-to-zoladex-treatment